We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type


Firm name


298 results found


Foley & Lardner LLP | USA | 28 Jul 2016

Advancing New Claims Under the Lanham Act

Implementing unique litigation tactics, on June 15, 2016, Foley & Larder LLP filed a complaint under Section 337 of the Tariff Act at the


Hamilton Brook Smith & Reynolds PC | USA | 26 Jul 2011

How the new multi-party patent infringement rulings will affect pharmaceutical treatment claims

The very recent and continuing focus by the U.S. Supreme Court and the Federal Circuit sitting en banc on multi-party infringement issues namely, induced infringement and divided, or joint, infringement portends daunting new challenges for brand pharmaceutical companies that attempt to assert method of treatment claims in Hatch-Waxman litigation against generic competitors.


Cadwalader Wickersham & Taft LLP | USA | 13 Jul 2010

Without affirmative act by patentee, Federal Circuit rejects declaratory judgment suit by potential infringer

A recent Federal Circuit decision shows that even under the liberalized standard for declaratory judgment jurisdiction set forth in MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007), and SanDisk Corp. v. STMicrolectronics, Inc., 480 F.3d 1372 (Fed. Cir. 2007), a party that is uncomfortable about the existence of another's patent but has not been accused of infringement may have difficulty establishing the existence of a case or controversy sufficient to support a declaratory judgment action against the patentee.


Locke Lord LLP | USA | 13 Oct 2008

Section 271(e)(1) safe harbor applies to cases on imported products made by patented processes

After a patentee appealed the decision of the International Trade Commission (ITC), the Federal Circuit held that the ITC properly applied the infringement safe harbor under 35 U.S.C. 271(e)(1) in a proceeding against the allegedly unlawful importation of products made by a patented process.

Previous page 1 2 3 ...